Caxton Associates LP Repligen Corp Transaction History

Caxton Associates LP

  • $2.91 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $200,028 - $332,963
-1,027 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $170,348 - $226,915
1,027 New
1,027 $205,000
Q2 2020

Aug 14, 2020
SELL
$94.33 - $140.48 $574,281 - $855,242
-6,088 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$84.96 - $109.14 $517,236 - $664,444
6,088 New
6,088 $588,000

Others Institutions Holding RGEN

# of Institutions
495
Shares Held
53.9M
Call Options Held
420K
Put Options Held
85.3K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.26B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email